Our faculty research in diverse subjects: psychosomatic issues, pain management, patient reporting and compliance behaviors, whole community and family roles in psychiatric conditions and treatment, teaching strategies and much more.
Strong Foundations: Intervening to Promote Co-Parenting and Reduce Father Hazardous Drinking in Expectant Parents. Kurt Dermen (Co-Investigator). National Institute on Alcohol Abuse and Alcoholism. $2,246,077. 5/1/2019-4/1/2024.
A 26-week, Multicenter, Open-label, Flexible-dose Study to Evaluate the Long-term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants with Schizophrenia or Bipolar I Disorder (3070-30-001), Abbvie. Steven Dubovsky (Principal Investigator). Abbvie. $150,000. 1/1/2021-12/1/2023.
A phase II randomized, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of 4 oral doses of BI 1358894 once daily over 12 week treatment period in patients with borderline personality disorder, Boehringer Ingelheim. Steven Dubovsky (Principal Investigator). Boehringer Ingelheim. $200,000. 1/1/2021-12/1/2023.
Faculty in the Division of Forensic Psychiatry study how psychological and neurobiological factors relate to criminal behavior in people with psychiatric illnesses.
We sustain a related program of research investigating the factors, especially neurobiological mechanisms, that contribute to the manifestation of violence in schizophrenia.
Our faculty use the Child and Family Asthma Studies Center to study how family relations impact anxiety, depression and stress-related illness in children and adolescents.
Our faculty lead projects at the interdisciplinary Research Institute on Addictions, focusing on the relationships among alcohol abuse, violence and marital and family processes.
The ongoing clinical study iCare seeks to identify how family stress and depression function as obstacles to adherence to treatment for patients with cystic fibrosis.
At our department’s one-of-a-kind Child and Family Asthma Studies Center, we study how stress and depression impact disease, using a laboratory-based stress paradigm.
The search for more effective pharmacological treatments for mood disorders relies on a more thorough and accurate understanding of these disorders’ etiology.
Our innovative program Child and Adolescent Psychiatry for Primary Care (CAP-PC) is evaluating a new model for providing child psychiatric consultation to pediatricians.
In this custom-designed psychophysiology lab, our faculty, residents and fellows study the mechanisms by which the mind affects the body in psychosomatic illness by measuring heart rate and heart rate variability under lab stress conditions.